Containing Or Obtained From A Fruit (aka Fructus), Including Berry Patents (Class 424/777)
-
Publication number: 20150050374Abstract: The present invention relates to a dietary supplement composition made of: linolenic expeller pressed soybean oil in the range of 65%-85%, Omega 3 (18/12) fish oil 15%-35%, 1%-20% alpha-tocopherol, and 7.5%-15% acai berry powder and a method to use this composition to supplement the diet of a domestic animal, such as a canine or an equine.Type: ApplicationFiled: March 27, 2014Publication date: February 19, 2015Applicant: Equine Mega-Omega, LLCInventor: Murray Fulgham
-
Publication number: 20150050342Abstract: Compositions are provided comprising: (i) chlorhexidine or a pharmaceutically acceptable salt thereof; (ii) niacinamide or niacin; and (iii) salicylic acid or a pharmaceutically acceptable salt or derivative thereof. The compositions are suitable for use in treating and preventing disorders of the skin. The compositions are also provided in the form of cosmetic products.Type: ApplicationFiled: July 20, 2012Publication date: February 19, 2015Inventors: Nicholas Lowe, Philippa Lowe
-
Patent number: 8945639Abstract: The present invention relates to compositions (including medicaments and nutritional products) for use in the prevention or treatment of Inflammatory Bowel Disease. Such compositions comprise a therapeutically effective amount of a soluble fiber derivable from fruit of the Musa spp. The soluble fiber may in particular be derived from plantains or bananas.Type: GrantFiled: June 16, 2011Date of Patent: February 3, 2015Assignee: Provexis (IBD) LimitedInventor: Jonathan Rhodes
-
Patent number: 8945640Abstract: A method of preparing genipin-rich materials from the fruit of Genipa americana fruit for their use as a cross-linking agent and as a raw material to produce colors is disclosed. The genipin-rich materials can be used in a broad range of applications including personal care, cosmetics, dietary supplements, packaging, textiles, beverages, foodstuffs, drugs, and animal feeds.Type: GrantFiled: November 7, 2012Date of Patent: February 3, 2015Assignee: WILD Flavors, Inc.Inventors: Shaowen Wu, Gregory Horn
-
Publication number: 20150030710Abstract: The present invention relates generally to a composition comprising palm fruit juice for use in a method of preventing and inhibiting vision loss due to angiogenesis related diseases. The composition of the present invention aids to decrease in CNV size using confocal microscopy, in addition to reduction in macrophage infiltration using immune staining; decrease in VEGF-A-induced angiogenesis using established cornea pocket assay, inhibition of IKB-D phosphorylation in laser treated choroidal tissues and reduction in macrophage recruitment to CNV lesions.Type: ApplicationFiled: August 5, 2014Publication date: January 29, 2015Inventors: Ali Hafezi MOGHADAM, Ravigadevi SAMBANTHAMURTHI, Yew Ai TAN, Kalyana Sundram P. MANICKAM, Kenneth C. HAYES, Zandi SOUSKA
-
Publication number: 20150030709Abstract: The invention relates to cardio-protective agents. In particular, the present invention relates to de-sugared cardio-protective extracts and fractions thereof prepared from kiwi fruit.Type: ApplicationFiled: February 20, 2013Publication date: January 29, 2015Applicant: University of OsloInventor: Asim Kanti Duttaroy
-
Publication number: 20150030550Abstract: The present invention relates to a composition including at least one C7 sugar, or derivative from esterification of said sugar, and a pharmaceutically acceptable carrier for treating alopecia. The present invention also relates to a method for cosmetically treating hair and nails, said method being intended to stimulate the growth thereof and/or slow the loss thereof. According to said method, a cosmetic composition including at least one C7 sugar, or derivative from esterification of said sugar, is administered. The present invention finally relates to a method for cosmetic care of hair and/or eyelashes and/or nails.Type: ApplicationFiled: October 15, 2014Publication date: January 29, 2015Applicant: LABORATOIRES EXPANSCIENCEInventors: Caroline BAUDOUIN, Philippe MSIKA
-
Publication number: 20150024060Abstract: The present disclosure describes economical processes to improve the bioavailability of nutraceuticals by formulations that induce micronization and sustained release. The inventive process can be used to increase the solubility and bioavailability of lipophilic and moderately water-soluble nutraceuticals by combining excipients that increase the solubility and induce sustained release of the active compounds. The inventive process also can be used to increase the residence time of highly water-soluble nutraceuticals that are metabolized and eliminated quickly from the body, consequently increasing the therapeutic potential. The disclosed formulations advantageously are freely flowing powders that can be used to formulate with other ingredients into tablets, capsules, or the like; or used as bulk powders.Type: ApplicationFiled: September 12, 2014Publication date: January 22, 2015Applicant: BIOACTIVES LLCInventors: Doddabele L. Madhavi, Daniel I. Kagan
-
Patent number: 8936818Abstract: A pomegranate beverage including a pomegranate juice component prepared by crushing and squeezing whole fruits of pomegranate including inner and outer peels and seeds to yield a juice component and an insoluble by-product component, where the juice component separated from the insoluble by-product component to obtain the pomegranate juice component, and an amount of a pomegranate extract component including at least 30 to 3000 ?mols of polyphenols, where the beverage is prepared by a process including re-suspending the insoluble by-product component in an aqueous medium, mixing the re-suspended insoluble by-product component and the aqueous medium, and separating an aqueous extract from the insoluble by-product component to obtain the pomegranate extract component, where the aqueous extract includes polyphenols resulting from the insoluble by-product component.Type: GrantFiled: June 29, 2012Date of Patent: January 20, 2015Assignee: POM Wonderful, LLCInventors: Michael Aviram, Leslie Dornfeld
-
Patent number: 8927035Abstract: One or more embodiments of the invention are directed to methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans. The methods comprise the step of administering to the patients a composition comprising a therapeutically effective amount of an extract from pomegranate.Type: GrantFiled: March 26, 2014Date of Patent: January 6, 2015Assignee: POM Wonderful, LLCInventor: Michael Aviram
-
Publication number: 20150004268Abstract: The invention is in particular concerned with a food product comprising one or more fats or oils and a carotenoid compound. The products of the invention may be used in reducing elevated total cholesterol, triglycerides and inflammatory damage, as well as improving tissue microcirculation and tissue oxygenation.Type: ApplicationFiled: December 13, 2012Publication date: January 1, 2015Applicant: IP SCIENCE LIMITEDInventor: Ivan Petyaev
-
Publication number: 20140377338Abstract: The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light- and/or air-blocking packaging.Type: ApplicationFiled: September 8, 2014Publication date: December 25, 2014Inventor: Marius Morariu
-
Publication number: 20140370136Abstract: Disclosed are a fermented pomegranate oil composition wherein pomegranates are immersed in edible vegetable oil so that the pomegranates are fermented under anaerobic conditions and active ingredients of the pomegranates are efficiently released to the edible oil to obtain edible vegetable oil containing active ingredients of pomegranates which is useful for cosmetics, functional foods and medicine materials, and a method of preparing the same.Type: ApplicationFiled: November 15, 2013Publication date: December 18, 2014Inventor: Sung Hag KOO
-
Patent number: 8911804Abstract: Disclosed is a composition for use as an antioxidant, such as for use as an anti-aging supplement. The composition can include a muscadine (Vitis rotundifolia) pomace extract having a polyphenol content of at least 2% and trans-resveratrol from a source other than muscadine with a minimum purity of at least 5%. In an example, the ratio of muscadine pomace extract polyphenols to trans-resveratrol is in the range of 0.1/1 to 10/1 (weight to weight), thereby providing a composition with antioxidant activity. Also disclosed are methods of producing antioxidant compositions. These methods can include combining a muscadine pomace extract having a polyphenol content of at least 2% and resveratrol from a source other than muscadine with a minimum purity of at least 5% at a ratio in the range of 0.1/1 to 10/1 (weight to weight), thereby providing a composition with antioxidant activity.Type: GrantFiled: September 23, 2013Date of Patent: December 16, 2014Assignee: Shaklee CorporationInventors: Laurel A. Fisher, Teodoro T. Ianiro, William J. Mergens, Nasrin Zamanian
-
Publication number: 20140356340Abstract: Nutritional products having improved cohesiveness of food boluses and methods of making and using same are provided. The nutritional products may include nutritional compositions and high molecular weight, water-soluble polymers such that the nutritional products have extensional viscosities that provide improved cohesiveness to the nutritional products and Trouton ratios of at least 6. Methods of administering such nutritional products to patients having impaired swallowing ability and/or dysphagia are also provided.Type: ApplicationFiled: December 17, 2012Publication date: December 4, 2014Inventors: Adam Burbidge, Jan Engmann, Simina Popa Nita
-
Publication number: 20140348873Abstract: Compositions and methods for urea silicone gels for treating hyperkeratotic skin diseases that may benefit from barrier protection and from urea silicone gel's ability to return water balance to the skin are disclosed. Skin conditions that may be treated with urea silicone gels may be excessive dryness, callus, corns, old and new scars, and keloids, among others. Disclosed urea silicone gels may include micronized urea USP, and an anhydrous silicone base, among other ingredients. Anhydrous silicone base may include Amazonian oils such as pracaxi oil and seje oil, which are rich in oleic, linolenic, linoleic acids, and sterols, particularly beta-sitosterol and stigmasterol, which may increase skin permeability to urea. Additionally, because of the high content of unsaturated fatty acids of pracaxi oil and seje oil, disclosed urea silicone gel may exhibit an enhanced hydrating effect on skin cells, over-moisturizing and hydrating tough, thick hyperkeratotic conditions.Type: ApplicationFiled: May 22, 2013Publication date: November 27, 2014Applicant: PROFESSIONAL COMPOUNDING CENTERS OF AMERICAInventor: Fabiana Campanati Banov
-
Patent number: 8894979Abstract: The present invention relates to a composition including at least one C7 sugar, or derivative from esterification of said sugar, and a pharmaceutically acceptable carrier for treating alopecia. The present invention also relates to a method for cosmetically treating hair and nails, said method being intended to stimulate the growth thereof and/or slow the loss thereof. According to said method, a cosmetic composition including at least one C7 sugar, or derivative from esterification of said sugar, is administered. The present invention finally relates to a method for cosmetic care of hair and/or eyelashes and/or nails.Type: GrantFiled: December 15, 2010Date of Patent: November 25, 2014Assignee: Laboratoires ExpanscienceInventors: Caroline Baudouin, Philippe Msika
-
Publication number: 20140342010Abstract: The present invention provides a method of using Polygonum multiflorum or extracts thereof to enhance stem cell mobilization in a subject, including hematopoietic stem cells (HSCs) and bone marrow stem cells (BM-SCs). In one embodiment, a blended composition of plant parts, fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote mobilization of stem cells, resulting in migration of the stem cells to specific sties of maintenance and repair within tissues and/or organs. Increased circulation of HSCs and/or BMSCs and migration towards sites of maintenance promotes the natural regeneration mechanisms in the body.Type: ApplicationFiled: November 15, 2012Publication date: November 20, 2014Applicant: Stemtech International, Inc.Inventors: Christian Drapeau, Gitte S. Jensen
-
Patent number: 8889116Abstract: A dispenser for an animal attractant including: a housing, wherein the housing includes a chamber for containing a spool; a spool, wherein the spool is associated with the chamber of the housing, and wherein the spool is associated with a deer attractant; and wherein the deer attractant includes a substrate, wherein the substrate is associated with an agent wherein the agent includes a deer attractant.Type: GrantFiled: May 10, 2007Date of Patent: November 18, 2014Assignee: Deer On A String, Inc.Inventors: Joel D. Potgeter, Michael A. Rose, David L. Ver Burg, John E. Bramer
-
Publication number: 20140335209Abstract: There is provided a process for making a composition suitable for topical application comprising the steps of a) heating at least one fruit and/or vegetable pulp to up to a temperature in the range of about 40° C. to 100° C.; b) mixing between 1 and 40% w/w of a mild base with the heated fruit and/or vegetable pulp. There is also provided a fruit and/or vegetable derived composition suitable for topical application prepared by the above process. There is further provided a fruit and/or vegetable derived composition comprising at least one fruit and/or vegetable-derived pulp and a mild base, said composition having a pH in the range of about 7.5 to about 9.5.Type: ApplicationFiled: February 12, 2014Publication date: November 13, 2014Inventor: Thomas James MCARTHUR
-
Publication number: 20140335211Abstract: The present invention discloses a use of neohesperidin or a neohesperidin-containing plant extract in the manufacture of a product for improving and/or promoting skin microcirculation, or for eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation. The present invention also discloses a composition comprising an effective amount of neohesperidin or a neohesperidin-containing plant extract, and to a method for improving and/or promoting skin microcirculation, or eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation, by using neohesperidin. The skin microcirculation of the present invention is preferably eye skin microcirculation.Type: ApplicationFiled: November 25, 2011Publication date: November 13, 2014Applicant: NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTDInventors: Liu Hu, Hongying Lan
-
Patent number: 8877264Abstract: Disclosed herein is a. skin external composition containing ginseng berry extract. More specifically, disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract having the specific components and compositions, among the above-ground parts of ginseng, and thus promotes the production of collagen in the skin, shows an MMP-I inhibitory effect and, at the same time, has skin-aging inhibitory and wrinkle-reducing effects, resulting from antioxidant effects and DNA damage-protecting effects.Type: GrantFiled: May 30, 2008Date of Patent: November 4, 2014Assignee: Amorepacific CorporationInventors: Chan Woong Park, Myeong Hoon Yeom, Jin Young Lee, Hee Young Jeon, Sang Jun Lee, Nam Hoon Cho, Dong Sung Lee
-
Patent number: 8877259Abstract: Disclosed is a topical skin cleanser comprising Silybum marianum fruit extract, Momordica grosvenorii fruit extract, and a cosmetic vehicle comprising at least 50% by weight of the composition of water and disodium EDTA, glycerin, phenoxyethanol, triethanolamine, 3-Iodo-2-propynyl butyl carbamate, and benzyl alcohol.Type: GrantFiled: February 8, 2013Date of Patent: November 4, 2014Assignee: Mary Kay Inc.Inventors: Tiffany Florence, Michelle Hines, David Gan, Barbara Durkee
-
Publication number: 20140322358Abstract: The present invention is generally directed to compositions and methods for amelioration chronic renal failure and related symptoms in domestic animals. In one case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Fruit- and Vegetable-Based Additive. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Cesium and/or Rubidium salt. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Dehydrated Domestic Animal Food and a Phosphate Binder.Type: ApplicationFiled: April 24, 2014Publication date: October 30, 2014Inventor: Jeffrey Alan McKinney
-
Publication number: 20140314889Abstract: The invention relates to cardio-protective agents. In particular, the present invention relates to cardio-protective extracts and fractions thereof prepared from kiwi fruit.Type: ApplicationFiled: December 6, 2011Publication date: October 23, 2014Applicant: UNIVERSITY OF OSLOInventor: Asim Kanti Duttaroy
-
Publication number: 20140302181Abstract: The present invention discloses a drug screening method, drugs promoting extracellular matrix protein crosslinking and their applications, the said drug screening method, is used to screen out materials promoting the expression of LOXL1 gene, wherein, the said drug screening method contains the following steps: A, Construct the 2nd generation lentiviral vector used to control the ZsGreen expression by human LOXL 1 gene promoter. B, Infect human fibroblasts with the 2nd generation lentiviral vector, and construct the new human fibroblasts which integrate PLOXL1-ZsGreen components. C, Drug screening: Inoculate the said human fibroblasts integrating PLOXL1-ZsGreen components into culture medium. Add the analyte into the cell culture medium containing human fibroblast cells. After culturing, detect the green fluorescence intensity of these fibroblast cells, then decide if the analyte promotes LOXL1 gene expression by checking if the green fluorescence intensity is increased.Type: ApplicationFiled: December 28, 2012Publication date: October 9, 2014Inventors: Xiaoqing Liu, Ming Ying, Lihua Jian
-
Patent number: 8840936Abstract: The present invention relates to an herbal tea without excipient used as milk supplement. The herbal tea comprises the following medicinal materials: Raw Semen Coicis, Herba Lophatheri, Setaria Italica, Prepared Semen Coicis, Fructus Hordei Germinatus, Fructus Setariae Germinatus, Medulla Junci and Triticum Aestivum, wherein the Triticum Aestivum is used as a forming agent in the herbal tea. The method of preparing the herbal tea comprises the following steps: (a) weighing the medicinal materials according to the formula of herbal tea; (b) mixing the medicinal materials except for Triticum Aestivum together, decocting the resulting mixture with water 1-3 time(s), each time lasting for 0.5-2 hours, then combining the decoctions obtained from each time, filtering, and concentrating the resulting filtrate into a concentrated solution with relative density of 1.0-1.Type: GrantFiled: March 3, 2011Date of Patent: September 23, 2014Assignee: Eu Yan Sang International LtdInventors: Suet Ying Wong, Kim Wu, Kuen Kuen Ella Lee
-
Patent number: 8834941Abstract: This invention relates to methods for the treatment and prevention of metabolic disorders, digestive disorders, and pathological conditions related thereto whereby a patient is given a nutrient food combination comprising 1) mechanically processed bran and 2) meat or a dried product comprising fruit, vegetables, berries, or any combination thereof. Diluted vinegar may be included.Type: GrantFiled: November 30, 2009Date of Patent: September 16, 2014Inventor: Gela Sulaberidze
-
Patent number: 8828458Abstract: The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light- and/or air-blocking packaging.Type: GrantFiled: September 7, 2011Date of Patent: September 9, 2014Inventor: Marius Morariu
-
Publication number: 20140242204Abstract: The present invention relates to the ameliorating effects of C3G (Cyanidin-3-O-?-d-glucopyranoside) on diabetic erectile dysfunction. In particular, the present invention relates to a pharmaceutical composition and food composition for preventing or treating diabetic erectile dysfunction comprising C3G. In addition, the present invention relates to a pharmaceutical composition and food composition for preventing or treating diabetic erectile dysfunction comprising extract of mulberry containing C3G.Type: ApplicationFiled: March 22, 2012Publication date: August 28, 2014Applicant: CATHOLIC UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Sae-Woong Kim, Myung-Hoon Chun, In-Beom Kim, U-Syn Ha, Sun-Jin Kim, Woong-Jin Bae, Yong-Sun Choi
-
COMPOSITION AND METHOD OF OBTAINING ORAL OR ENTERAL DOSAGE FORMS OF PHYTOCHEMICALS FROM POMEGRANATES
Publication number: 20140242164Abstract: Nutraceutical compositions for improved administration of important phytochemicals from pomegranate to a human or animal. More particularly, enables oral or enteral dosage forms containing phytochemicals from pomegranate for administering on a routine basis. In at least one instance the natural contents of a pomegranate are encapsulated into a pill form or concentrated juice that provides for more efficient administration than eating a pomegranate but contains the same key ingredients present in the fruit. Enables the recipient to receive the benefits of the fruit but allows for the dosages to be taken in pill or concentrated juice form. Composition is chemically similar or equal to a natural pomegranate but is in a powder, pill or concentrated liquid form.Type: ApplicationFiled: May 5, 2014Publication date: August 28, 2014Applicant: POM Wonderful, LLCInventors: Steve Anderson, Mark Dreher -
Patent number: 8815305Abstract: A composition which includes a pulp extract from the fruit of Argania spinosa and at least one dermopharmaceutical or cosmetic auxiliary and/or additive is provided. A process for producing an extract from the fruit of Argania spinosa, and a triterpene fraction of an extract of the pulp of the fruit of Argania spinosa including lupeol, ?-amyrine, ?-amyrine, taraxasterol, and psi-taraxasterol are also provided.Type: GrantFiled: October 15, 2004Date of Patent: August 26, 2014Assignee: BASF Beauty Care Solutions France S.A.S.Inventors: Florence Henry, Louis Danoux, Gilles Pauly, Zoubida Charrouf
-
Publication number: 20140227204Abstract: Skin compositions comprising, hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and related method for protecting, healing and/or soothing the skin comprising: applying an effective amount of a cosmetic preparation selected from the group consisting of hand cream, foot cream, body cream, lip cream, lip gloss, lip stick, gel, balm and lotion to the skin surface; wherein said cosmetic preparation includes a skin composition made of hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and said effective amount is enough to protect, heal and/or soothe the skin surface.Type: ApplicationFiled: February 11, 2013Publication date: August 14, 2014Inventor: Norman Turkowitz
-
Patent number: 8802161Abstract: The invention describes a nutraceutical composition and method for preventing/treating cancer or augmenting chemotherapy in advanced stage malignancies; comprised of [1] tumoricidal herbs; beth root, galbanum, gromwell root, wild yam, balm of gilead bud, frankincense, [2] an antiproliferative herb; speranskia [3] a natural lactic acid dehydrogenase (LDH) inhibitor, 2?,3,4?5,7-pentahydroxyflavone or cinnamon, [4] alkalizing agents: calcium, magnesium, potassium or bicarbonate salts, barley grass, chlorella and spirulina [5] at least one quinone and [6] at least one agent capable of maximizing oxidative mitochondrial function preferably riboflavin, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin and a pharmaceutically acceptable carrier.Type: GrantFiled: January 30, 2010Date of Patent: August 12, 2014Assignee: Florida Agricultural and Mechanical UniversityInventors: Elizabeth Anne Mazzio, Karam F Soliman
-
Patent number: 8790727Abstract: Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with Morinda citrifolia and iridoids.Type: GrantFiled: February 22, 2011Date of Patent: July 29, 2014Assignee: Tahitian Noni International, Inc.Inventors: Brett Justin West, Claude Jarakae Jensen, Afa Kehaati Palu, Shixin Deng, Jeffrey A. Wasden
-
Patent number: 8790718Abstract: An anti-norovirus agent that has high norovirus-inactivating activity and is safe for the human body, and an anti-norovirus composition that contains the anti-norovirus agent and is useful for disinfection and infection control against the norovirus. The anti-norovirus agent includes, as an active ingredient, an extract from a plant of the genus Diospyros containing tannin (hereinafter referred to as a “persimmon extract”), preferably a persimmon extract produced by heating squeezed juice or an extract from the fruit of a plant of the genus Diospyros or treating the squeezed juice or the extract with an alcohol. The anti-norovirus composition contains the anti-norovirus agent and at least one selected from the group consisting of alcohols, surfactants, antimicrobial agents, humectants, and cosmetic fats and oils, and preferably further containing an organic acid, such as citric acid, and/or a salt thereof or vitamin C.Type: GrantFiled: September 13, 2012Date of Patent: July 29, 2014Assignees: Hiroshima University, Altan Co., Ltd.Inventors: Tadashi Shimamoto, Toru Tsuji, Yoshiaki Nakai
-
Publication number: 20140205550Abstract: A method of cosmetic care comprising activating capsase-14 expression in skin deficient in caspase-14 expression by applying, on at least one skin zone in need thereof, an effective amount of a plant extract selected from the group consisting of litchi, glasswort, peach, soja seed, sweet basil, cucumber, chanterelle, leek, kiwi fruit, rhubarb, grapefruit, wheat, raspberry, plum, and mixtures thereof, to activate caspase-14 expression in said skin.Type: ApplicationFiled: January 23, 2013Publication date: July 24, 2014Inventors: Hugo A. Corstjens, Lieve Declercq, Gerry Eyckmans, Luc F.J. Van Overloop
-
Publication number: 20140205691Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.Type: ApplicationFiled: May 16, 2012Publication date: July 24, 2014Applicants: YUNGJIN PHARM.CO., LTD., JEONNAM BIOINDUSTRY FOUNDATIONInventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Ka Hyon Park, Hee Sook Kim, Wook Jin Jang, Hyun Kim, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim
-
Publication number: 20140205692Abstract: One or more embodiments of the invention are directed to methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans. The methods comprise the step of administering to the patients a composition comprising a therapeutically effective amount of an extract from pomegranate.Type: ApplicationFiled: March 26, 2014Publication date: July 24, 2014Applicant: POM Wonderful, LLCInventor: Michael AVIRAM
-
Patent number: 8778424Abstract: Provided are compositions containing a unique combination of vitamin B1, vitamin B6, vitamin B12, folic acid, magnesium glycinate, ferric glycinate, L cysteine, biotin, Polygonum multiflorum, and Emblica officinalis. Methods of increasing hair volume in a subject by administering to the subject a composition containing vitamin B1, vitamin B6, vitamin B12, folic acid, magnesium glycinate, ferric glycinate, L cysteine, biotin, Polygonum multiflorum, and Emblica officinalis are also included.Type: GrantFiled: January 3, 2012Date of Patent: July 15, 2014Inventor: Tasneem Bhatia
-
Patent number: 8778422Abstract: In order to provide a composition for the treatment of degenerative joint diseases with an improved efficacy, it is proposed that the composition comprises collagen hydrolysate and rosehip powder and/or extract, wherein the weight ratio of collagen hydrolysate to rosehip powder and/or extract, in each case in relation to dry mass, lies in the range of approximately 2:1 to approximately 100:1.Type: GrantFiled: December 20, 2011Date of Patent: July 15, 2014Assignee: Gelita AGInventor: Steffen Oesser
-
Patent number: 8771764Abstract: The present invention relates to a composition for the use in improving vascular health, including treating and preventing vascular diseases and diseases related thereto, using a botanical extract of oil palm vegetation liquor from the palm oil milling process.Type: GrantFiled: June 8, 2010Date of Patent: July 8, 2014Assignees: Malaysian Palm Oil Board, Commonwealth Scientific and Industrial Research Organisation (CSIRO)Inventors: Mahinda Abeywardena, Ravigadevi Sambanthamurthi, Yew Ai Tan, Kalyana Sundram P. Manickam, Mohd Basri Wahid
-
Patent number: 8765192Abstract: A method of topically applying natural plant product for dissipation of human adipose tissue, comprising: (a) topically applying an inner portion of a natural plant product to an epidermal layer exterior to adipose tissue to be dissipated of a user's body for a period of time, upon which a percentage of the adipose tissue softens and dissolves, thus, reducing the adipose tissue of the user's body; (b) removing the topically applied inner portion of the natural plant product from the epidermal layer for another period of time; (c) repeating steps (a) and (b); and weight reduction apparatus comprising a topical applicator having a receiving container adapted to removably receive a natural plant product and having an opening or a porous wall adapted to facilitate pulp, juices, and/or extracts of the natural plant product to contact a user's epidermal layer exterior to the adipose tissue to be dissipated.Type: GrantFiled: November 20, 2010Date of Patent: July 1, 2014Inventor: Joseph Lichtenstein
-
Patent number: 8758832Abstract: Nutraceutical compositions for improved administration of important phytochemicals from pomegranate to a human or animal. More particularly, enables oral or enteral dosage forms containing phytochemicals from pomegranate for administering on a routine basis. In at least one instance the natural contents of a pomegranate are encapsulated into a pill form or concentrated juice that provides for more efficient administration than eating a pomegranate but contains the same key ingredients present in the fruit. Enables the recipient to receive the benefits of the fruit but allows for the dosages to be taken in pill or concentrated juice form. Composition is chemically similar or equal to a natural pomegranate but is in a powder, pill or concentrated liquid form.Type: GrantFiled: May 7, 2007Date of Patent: June 24, 2014Assignee: POM Wonderful LLCInventors: Steve Anderson, Mark Dreher
-
Patent number: 8758833Abstract: The present invention relates to a cosmetic, nutraceutical or dermatological composition for treating or preventing acne, comprising a peptide and oside extract of Schizandra fruit and a suitable excipient. Preferably, the extract is obtained from Schizandra sphenanthera. The composition may also comprise at least one anti-acne agent selected from a sebum-regulating agent, an antibacterial and/or antifungal agent, a keratolytic agent and/or a keratoregulating agent, an astringent, an anti-inflammatory and/or anti-irritant, an antioxidant and/or a free-radical scavenger, a cicatrizing agent, an anti-ageing agent and a moisturizing agent. The invention also relates to a method for cosmetic treatment of acne, characterized in that a cosmetic composition according to the invention is applied to the affected areas of the skin, or in that the affected individual takes a nutraceutical composition according to the invention orally.Type: GrantFiled: July 27, 2010Date of Patent: June 24, 2014Assignee: Laboratoires ExpanscienceInventors: Sebastien Garnier, Dalale Naaimi, Caroline Baudouin
-
Patent number: 8758837Abstract: A method for removing pests from harvested vegetables has steps of extracting a first portion of harvested vegetables to obtain a vegetable cleanser, and cleaning a second portion of harvested vegetables with the vegetable cleanser, such that pests residing on the second portion of harvested vegetables are removed from the second portion of harvested vegetables, wherein the first portion of harvested vegetables and the second portion of harvested vegetables independently contain vegetables selected from the group consisting of vegetables belonging to the families of Cruciferae, Compositae, Chenopodiaceae and Amaranthaceae. The aforementioned method is effective at removing pests from harvested vegetables and satisfies urgent needs to reduce use of chemical pesticides.Type: GrantFiled: July 2, 2009Date of Patent: June 24, 2014Assignee: Food Industry Research & Development InstituteInventors: Tin-Yin Liu, Yi-Kai Wang, Mei-Ling Lu
-
Patent number: 8758835Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.Type: GrantFiled: July 24, 2009Date of Patent: June 24, 2014Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.Inventors: Franco Gaetani, Ashraf Virmani
-
Patent number: 8747927Abstract: Disclosed are compositions and corresponding methods of their use that include jaboticaba fruit pulp and/or cashew fruit pulp or extracts thereof.Type: GrantFiled: August 25, 2011Date of Patent: June 10, 2014Assignee: Mary Kay Inc.Inventors: Tiffany Florence, David Gan, Michelle Hines
-
Patent number: 8741362Abstract: The invention relates a phytocomplex obtained from the bergamot fruit albedo (Citrus Bergamia Risso & Poiteau), the production thereof and the use thereof, in particular under the form of dry extract, to be used as normalizer of the metabolic unbalances of lypemic and glycemic type, in the treatment of the cutaneous diseases with inflammatory or degenerative character, as painkilling/anti-inflammatory agent, as antineoplastic agent and dietary supplement.Type: GrantFiled: November 13, 2009Date of Patent: June 3, 2014Assignee: Herbal & Antioxidant Derivatives S.R.L.Inventors: Giuseppe Lombardo, Domenico Malara, Vincenzo Mollace
-
Publication number: 20140147537Abstract: Provided are methods of making an extract of fruit of the Solanaceae family wherein fruit is processed to optimise the platelet aggregation inhibiting activity of the extract. The methods involve preparing a start mix of homogenised fruit; separating a water soluble fraction from fruit solids; filtration of the water soluble fraction; and concentration of active agents in the filtration permeate. The invention also provides fruit extracts manufactured by such methods, and also fruit extracts containing glycosylated phenolic acid or a phenolic ester, or derivatives thereof, a glycosylated flavonoid; and a nucleoside. The extracts of the invention are useful as medicaments for the treatment or prevention of a medical condition characterised by inappropriate platelet aggregation. In particular, the medicaments may be of use in maintaining heart health by reducing platelet aggregation; benefiting the circulation; and/or normalizing or otherwise benefiting blood flow.Type: ApplicationFiled: September 18, 2013Publication date: May 29, 2014Inventor: Niamh O'Kennedy